Navigation Links
Simbionix Launches Innovative Patient-Specific Simulation

CLEVELAND, Ohio, October 3 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, advances procedural simulation from theoretical promise to operating room reality.

The PROcedure Rehearsal Studio(TM), Simbionix' latest innovative medical simulation system, is the world's first medical simulator that enables clinicians to create practice scenarios based on their patient's unique pathology and anatomy.

Dr. Karl Illig, Chief of Vascular Surgery at Strong Medical Center in Rochester, NY, explains why physicians are eager to start using the new simulator: "PROcedure Studio helps us identify pitfalls and problems and solve them on the machine. If we're going to make a mistake, let's make it on the simulators first."

Gary Zamler, CEO of Simbionix, sees the launch of Procedure as "a quantum leap in the world of medical simulation that has the potential to significantly improve patient outcomes while reducing health care costs."

"Our leading technology has made Simbionix the industry leader in medical simulation. PROcedure Rehearsal Studio shows where that leadership will be taking everyone."

Mr. Zamler also announced that Strong Medical Center in Rochester, NY, Imperial College, UK, and Sheba Hospital, Israel have already signed agreements with Simbionix to use PROcedure Rehearsal Studio in their simulation centers.

"These leading hospitals will use and test PROcedure Rehearsal Studio in accordance with Simbionix' philosophy and mission to collaborate with the medical community developing leading-edge technologies for training and education while promoting patient safety."

Simbionix will unveil this next generation of medical simulation on October 12th at the Annual Transcatheter Cardiovascular Therapeutic symposium (TCT) in Washington, DC.

Company Description

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures.


Inbal Mazor

VP Marketing


Tel: +972-8-9211177

SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
2. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
3. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
4. CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
5. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
6. Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
7. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
8. Lena Chow, Veteran Biotech Marketer, Launches New Website
9. BioSpace Launches Life Science Career Content and Resources from the Biotech Work Portal
10. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
11. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
Post Your Comments:
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th until ... from 17 th until 19 th November ... has invented the first combined scanner in the world which scans ... Until now two different scanners were required: one for passports ... on the same surface. This innovation is an ideal solution ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
Breaking Biology News(10 mins):